ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : ILEX Pharmaceuticals


Include trials that are no longer recruiting patients.

4 studies were found.
1.RecruitingClofarabine alone versus Clofarabine in Combination with Low-Dose Cytarabine (ara-C) in Previously Untreated Patients with Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome
2.RecruitingFludara plus Alemtuzumab (Campath, MabCampath) vs Fludara alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) patients
Condition: B-Cell Lymphocytic Leukemia
3.RecruitingPhase I/II Study of CAMPATH in Patients with Relapsing or Refractory Non-Hodgkin’s Lymphoma
Condition: Non-Hodgkins Lymphoma
4.RecruitingRituximab plus CAMPATH in Patients with Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL
Condition: Non-Hodgkin's Lymphoma

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act